Tesla, AT&T, Alphabet, Chipotle, Visa, and More Stocks to Watch This Week
Second-quarter earnings season continues with Verizon, Alphabet, Coca-Cola, Comcast, General Motors, Tesla, Visa, AT&T, Chipotle, and Newmont.
Labcorp, Quest Among Health Firms to Cite Impact From CrowdStrike Issue
Express News | Quest Diagnostics - Patient Services & Customer Contact Teams Operating With Reduced Capacity, so Customers May Experience Longer Wait & Service Times
Express News | Quest Diagnostics Says Taking Swift Action to Respond, Recover and Restore Operations Due to Global Information Outage That Occurred This Morning
Lisata to Use Haystack Technology to Evaluate Pancreatic Cancer Asset Certepetide
Express News | Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack Mrd™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
EXCLUSIVE: Lisata Therapeutics Tells Benzinga Co. And Haystack Oncology Initiate Research Collaboration To Use The Haystack MRD Technology To Evaluate Efficacy Of Pancreatic Cancer Therapy
EXCLUSIVE: Lisata Therapeutics Tells Benzinga Co. And Haystack Oncology Initiate Research Collaboration To Use The Haystack MRD Technology To Evaluate Efficacy Of Pancreatic Cancer
EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy
Haystack Oncology, a Quest Diagnostics Inc. (NYSE:DGX) company, announced a research collaboration with Lisata Therapeutics Inc. (NASDAQ:LSTA).Haystack Oncology developed Haystack MRD, a next-
Here's Why Quest Diagnostics (DGX) Is a Strong Value Stock
Quest Diagnostics Price Target Raised to $158.00/Share From $150.00 by Truist Securities
Quest Diagnostics Price Target Raised to $158.00/Share From $150.00 by Truist
Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $158
Truist Financial analyst David S Macdonald maintains $Quest Diagnostics(DGX.US)$ with a hold rating, and adjusts the target price from $145 to $158.According to TipRanks data, the analyst has a
Quest Diagnostics (DGX) Set to Acquire OhioHealth's Lab Services
Truist Securities Adjusts Price Target on Quest Diagnostics to $158 From $150, Maintains Hold Rating
Quest Diagnostics (DGX) has an average outperform rating and a price target range of $136 to $165, according to analysts polled by Capital IQ.
Is Quest Diagnostics Incorporated (DGX) an Undervalued High Growth Stock?
Express News | Quest Diagnostics Inc : Leerink Partners Raises Target Price to $151 From $141
What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?
Quest Diagnostics to Purchase Outreach Lab Assets From Health System OhioHealth
Citi Upgrades Illumina, Quest, Agilent to Buy, Downgrades Avantor
Express News | Quest Diagnostics Inc: Financial Details of Transaction Were Not Disclosed.
Express News | Quest Diagnostics to Acquire Outreach Laboratory Services of Ohiohealth